Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan 11:23:e933792.
doi: 10.12659/AJCR.933792.

A Well-Differentiated Grade-3 Neuroendocrine Tumor in the Ascending Colon: A Case Report

Ali AlSaffar  1 , Sarah Wood  1 , Fatma AlRabiy  2 , Dany Hamie  3 , Salah Termos  1
Affiliations
Case Reports

A Well-Differentiated Grade-3 Neuroendocrine Tumor in the Ascending Colon: A Case Report

Ali AlSaffar et al. Am J Case Rep. .

Abstract

BACKGROUND Gastrointestinal neuroendocrine tumors (NETs) are indolent hormone-secreting pathologic illnesses that can occur throughout the whole digestive tract. They are classified by site and grade. Colon neuroendocrine neoplasm (NEN) is an unusual histologic finding that needs to be further investigated. Well-differentiated (WD) Grade-3 (G3) is a new category of NEN that falls between neuroendocrine tumor (NET) and neuroendocrine carcinoma (NEC). CASE REPORT A 60-year-old man with a past medical history of diabetes mellitus presented with severe anemia and significant weight loss. Tumor markers (CEA and CA 19.9) were unremarkable. Colonoscopy showed a large fungating mass in the proximal part of the ascending colon. Biopsy results suggested colonic adenocarcinoma. Contrast-enhanced computed tomography of the chest, abdomen, and pelvis demonstrated a 5×5 cm ascending colon mass with few locoregional lymph nodes and no distant metastasis. A laparoscopic right hemicolectomy performed and histopathologic examination revealed T4N1, WD-NET G3. Postoperative completion work-up was done. Chromogranin-A was in the normal range and nuclear scans (PET and gallium 68) showed no abnormal uptake or residual disease. Extensive review, expert opinion, and multidisciplinary meetings failed to establish guidelines for adjuvant therapy due to the paucity of data in the literature. CONCLUSIONS Well-differentiated grade 3 NETs of the ascending colon is a rare finding in a rare disease. This entity of NENs is an unmet medical issue on the border between NET and NEC that remains a matter of great debate in terms of establishing an accurate diagnosis and outlining proper management.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1.
Figure 1.
Enhanced CT scan, axial and coronal cuts showing a large ascending colon mass (arrows).
Figure 2.
Figure 2.
Gross specimen of right hemicolectomy demonstrating a circumferential mass in the ascending colon extending to the serosa (arrows).
Figure 3.
Figure 3.
A low-power view of an invasive NET throughout the whole colonic wall from mucosa up to serosal surface.
Figure 4.
Figure 4.
Higher views of the tumor showing the rosette forming tubules with mild nuclear pleomorphism. Frequent mitosis is noted.
Figure 5.
Figure 5.
Ki-67 index expression reaching up to 60% in tumor cells. (A) Ki-67 index (20×). (B) Ki-67 index (40×).
Figure 6.
Figure 6.
Immunohistochemistry staining in tumor cells. (A) Chromogranin B positivity. (B) Synaptophysin positivity.
See this image and copyright information in PMC

References

    1. Ballantyne GH, Savoca PE, Flannery JT, et al. Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry. Cancer. 1992;69(10):2400–5. - PubMed
    1. Declore R, Friesen SR. Gastrointestinal neuroendocrine tumors. J Am Coll Surg. 1994;178(2):187–211. - PubMed
    1. Rindi G, Arnold R. WHO Classification tumours of the Digestive System. 4th ed. IARC; Lyon: 2010. Nomenclature and classification of neuroendocrine neoplasms of the digestive system; p. 13.
    1. Kytola S, Hoog A, Nord B, et al. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids. Am J Pathol. 2001;158:1803–8. - PMC - PubMed
    1. Rosenberg JM, Welch JP. Carcinoid tumors of the colon. A study of 72 patients. AM J Surg. 1985;149(6):775–79. - PubMed

Publication types

Substances